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A white 30-year-old woman presented with a 4-year history 
of a nodular lesion of the face that appeared to be growing 
and changing colour. Surgical excision without histolopatho-
ogical examination 3 years previously for the same lesion 
had resulted in a relapse 3 months later.
Physical examination showed a 1.3 cm erythematous, 
violaceous, multi-lobed tumour, with 2 pigmented satellite 
nodules on the right cheek (Fig. 1). Its surface was irregu-
lar with an infiltrated base extending to the subcutaneous 
tissue. The lesion was painless. 
A surgical excision was made with a margin of 3 mm 
in the macro scopic healthy skin. 
Pathological examination of the tumours revealed an 
asymmetrical lesion with dense proliferation of melanocy-
tic cells at the dermal–epidermal junction, with sheets of 
cells extending deep into the dermis and focally involving 
the deep margin. The dermal nests lacked maturation with 
depth. Cellular atypia, with some cells displaying enlarged, 
hyperchromatic nuclei and prominent nucleoli, and rare 
deep mitotic figures, were detected. Immunohistochemistry 
was positive for S-100, HBM-45 and Melan A.
What is your diagnosis? See next page for answer.
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Fig. 1. An erythematous violaceous multi-lobed tumour, with two pigmented 
satellite nodules on the right cheek.
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Diagnosis: Spitzoid melanoma
We consider this spitzoid lesion with atypical features to be 
spitzoid melanoma (SM), but we are aware that it is difficult 
to predict the biological behaviour with certainty from the 
histopathological appearance (Fig. 2).
The patient subsequently underwent a wide local re-
excision, with 2-cm margins. Physical examination was 
free of peripheral adenopathy and metastatic localizations 
(chest radiography, abdominal and cervical echography). 
The patient is currently being followed closely and shows 
no evidence of disease approximately 2 years later.
No single criterion or set of criteria enables Spitz naevus 
(SN) to be distinguished confidently from SM in all cases 
(1). Criteria to discriminate SN from the major differential 
diagnosis of cutaneous malignant melanoma were first 
published in 1947 by Sophie Spitz (2). In most cases, the 
diagnosis of a typical SN can be achieved by histopatho-
logical examination. In a subset of cases, however, it is 
almost impossible to differentiate between the two. 
Most authors (1–7) agree that the histological features 
that favour a diagnosis of melanoma include: moderate 
to marked dermal mitotic activity and/or the presence of 
atypical mitoses; prominent pagetoid (upward) epidermal 
spread of single (rather than nests of) tumour cells occur-
ring across the entire lesion, including at its periphery (in 
the absence of evidence of trauma); lack of maturity at the 
base of the lesion; nuclear hyperchromatism and cellular 
pleomorphism, ulceration and necrosis. Crotty et al. (5) 
demonstrated that the presence of abnormal mitoses, a 
dermal mitotic rate of > 2/mm2, and mitotic figures within 
0.25 mm of the deep border of the lesion favours a 
melanoma. Large nodules or confluent sheets of epithelioid 
melanocytes with nuclear and nucleolar pleomorphism and 
intraepidermal pagetoid spread are also more characteristic 
of malignant melanoma (1, 4).
New techniques have also demonstrated chromosomal, 
molecular and genetic differences between SN and mela-
nomas (8–11). However, there are currently no immunohis-
tochemical or other ancillary tests that are readily available 
and able to definitively distinguish SN from SM. 
The term SM probably best describes a rare group of 
tumours often developing in young individuals who are 
only diagnosed with melanoma in retrospect; that is, after 
the development of metastases and an aggressive course 
(5). Fewer than 50 cases of SM in young people have been 
reported in the literature (1–7). 
Our patient has SM of 2.75 mm Breslow depth without 
metastatic localization. Melanomas of similar thickness 
would have an estimated overall survival probability of 
40–85% over 9 years.
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Fig. 2. (a) Dense proliferation 
of melanocytic cells at the 
dermal–epidermal junction. (b) 
Note atypical features of spindle-
shaped melanocytes with mitoses. 
(Haematoxylin and eosin (a) ×10, 
(b) ×60).
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